Related Experiment Video

Updated: Mar 31, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.6K

Targeting tumor-stroma crosstalk: the example of the NT157 inhibitor

T Rampias1, R Favicchio2, J Stebbing2

  • 1School of Life Sciences, Department of Biochemistry and Biomedicine, University of Sussex, Brighton, UK.

Oncogene
|October 20, 2015
PubMed

Insights

A new drug, NT157, targets cancer's microenvironment by inhibiting IGF-1R and STAT3 pathways. This approach shows potential in reducing cancer cell survival and overcoming therapy resistance.

Area of Science:

  • Oncology
  • Cancer Biology
  • Tumor Microenvironment Research

Background:

  • Cancer progression and therapy resistance are influenced by tumor genetics and paracrine interactions within the tumor microenvironment (TME).
  • The TME's role in modulating drug sensitivity is a key area of focus for novel therapeutic strategies.
  • Targeting the TME offers a promising avenue for improving cancer treatment outcomes.

Purpose of the Study:

  • To investigate the potential of the novel anti-cancer drug NT157.
  • To evaluate the effects of NT157 on key signaling pathways within the TME.
  • To assess NT157's impact on cancer cell survival and drug resistance.

Main Methods:

  • Utilized preclinical models to assess the efficacy of NT157.
  • Investigated the inhibition of Insulin-like Growth Factor 1 Receptor (IGF-1R) and STAT3 signaling pathways.
  • Analyzed the drug's effects on both cancer cells and stromal cells within the TME.

Main Results:

  • NT157 demonstrated the ability to inhibit both IGF-1R and STAT3 signaling pathways.
  • The drug effectively targeted cancer cells and stromal cells within the TME.
  • Observed a decrease in cancer cell survival following NT157 treatment.

Conclusions:

  • NT157 shows promise as a therapeutic agent by targeting critical signaling pathways in the TME.
  • Inhibition of IGF-1R and STAT3 pathways by NT157 may overcome cancer progression and therapy resistance.
  • Targeting the TME with agents like NT157 represents a significant advancement in cancer treatment strategies.

More Related Videos

Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion05:48

Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion

Published on: March 18, 2014

10.2K
A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery07:20

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery

Published on: February 28, 2020

10.6K

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K